Top

Published in:

01-12-2008 | ORIGINAL CONTRIBUTION

Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers

Authors: Francesco Russo, Guglielmina Chimienti, Giuseppe Riezzo, Gabriella Pepe, Giuseppe Petrosillo, Marisa Chiloiro, Emanuele Marconi

Published in: European Journal of Nutrition | Issue 8/2008

Abstract

Background

Inulin has been suggested to have beneficial effects on lipids, especially on triglyceridemia. Few data are available about the effects of inulin on Lipoprotein(a), a low-density lipoprotein-like particle considered as an independent risk factor for atherosclerosis. Adding inulin to pasta could be a preventive strategy for delaying the onset of atherosclerosis.

Aim of the study

was to evaluate the effects of inulin-enriched pasta on lipid profile and on Lipoprotein(a) in young healthy subjects.

Methods

Twenty-two young healthy male volunteers entered a randomized double blind cross-over study consisting of a 2-weeks run-in period, a baseline assessment, two 5-weeks study periods (11% inulin-enriched or control pasta), and an 8-weeks wash-out period in between. Serum lipid concentrations were evaluated by routine biochemical analyses and plasma Lipoprotein(a) concentrations by ELISA. The size of apolipoprotein(a) isoforms was determined by Western blot and immunodetection.

Results

Significant differences at baseline and in the treatment groups were found for HDL-cholesterol (P = 0.004), total cholesterol/HDL-cholesterol ratio (P = 0.006), triglycerides (P = 0.04), and Lipoprotein(a) (P = 0.02) concentrations (data analyzed by Friedman test). Dunn’s multiple comparison test was used to assess the significance of differences between inulin-enriched pasta diet vs. baseline. HDL-cholesterol concentrations increased by 35.9%; total cholesterol/HDL-cholesterol ratio, triglycerides, and Lipoprotein(a) concentrations decreased by 22.2, 23.4, and 16.5% respectively.

Conclusions

Inulin-enriched pasta administration induced significant effects on lipid pattern parameters in young healthy volunteers, including a significant reduction in Lipoprotein(a) concentrations.

American Association of Cereal Chemists (2001) Approved methods of the AACC, 11th edn. AACC, St Paul

Andersson A, Tengblad S, Karlström B, Kamal-Eldin A, Landberg R, Basu S, Aman P, Vessby B (2007) Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. Br J Nutr 137:1401–1407

Brighenti F (2007) Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials. J Nutr 137(11 Suppl):2552S–2556S

Chimienti G, Russo F, Lamanuzzi BL, Nardulli M, Messa C, Di Leo A, Correale M, Giannuzzi V, Pepe G (2003) Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a). Clin Biochem 36:359–365CrossRef

Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY (2008) Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochem Biophys Res Commun 367:190–194CrossRef

Clerici C, Setchell KD, Battezzati PM, Pirro M, Giuliano V, Asciutti S, Castellani D, Nardi E, Sabatino G, Orlandi S, Baldoni M, Morelli O, Mannarino E, Morelli A (2007) Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 137:2270–2278

Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM (2005) Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr 59:723–726CrossRef

Delzenne NM, Daubioul C, Neyrinck A, Lasa M, Taper HS (2002) Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr 87(Suppl 2):S255–S259CrossRef

Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B (2000) HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 153:263–272CrossRef

10.

Friedewald WT, Levy RJ, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

11.

Giacco R, Clemente G, Luongo D, Lasorella G, Fiume I, Brouns F, Bornet F, Patti L, Cipriano P, Rivellese AA, Riccardi G (2004) Effects of short-chain oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr 23:331–340CrossRef

12.

Herrmann W, Biermann J, Kostner GM (1995) Comparison of effects of N-3 to N-6 fatty acids on serum level of Lipoprotein(a) in patients with coronary artery disease. Am J Cardiol 76:459–462CrossRef

13.

Kabir M, Oppert JM, Vidal H, Bruzzo F, Fiquet C, Wursch P, Slama G, Rizkalla SW (2002) Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 51:819–826CrossRef

14.

Kamboh MI, Ferrell RE, Kottke BA (1991) Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 49:1063–1074

15.

Katan MB, Zock PL, Mensink RP (1995) Dietary oils, serum lipoproteins, and coronary heart disease. Am J Clin Nutr 61(6 Suppl):1368S–1373S

16.

Kaur N, Gupta AK (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27:703–714CrossRef

17.

Keller KB, Lemberg L (2003) Obesity and the metabolic syndrome. Am J Crit Care 12:167–170

18.

Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, van der Schouw YT (2005) Dietary phytoestrogens and plasma lipids in Dutch postmenopausal women; a cross-sectional study. Atherosclerosis 178:95–100CrossRef

19.

Kronenberg F, Trenkwalder E, Dieplinger H, Utermann G (1996) Lipoprotein(a) in stored samples and the ravages of time: why epidemiological studies might fail. Arterioscler Thromb Vasc Biol 16:1568–1572

20.

Lara JJ, Economou M, Wallace AM, Rumley A, Lowe G, Slater C, Caslake M, Sattar N, Lean ME (2007) Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis 193:213–221CrossRef

21.

Letexier D, Diraison F, Beylot M (2003) Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 77(3):559–564

22.

Marconi E, Carcea M (2001) Pasta from nonnutritional raw materials. Cereal Foods Word 46:522–530

23.

McGill HC, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP (2000) Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 72:1307S–1315S

24.

Miller M, Seidler A, Moalemi A, Pearson TA (1998) Normal triglyceride levels and coronary artery disease events: the Baltimore coronary observational long-term study. J Am Coll Cardiol 31:1252–1257CrossRef

25.

Misra A (2000) Risk factors for atherosclerosis in young individuals. J Cardiovasc risk 7:215–229

26.

Nazih H, Nazih-Sanderson F, Krempf M, Michel Huvelin J, Mercier S, Bard M (2001) Butyrate stimulates ApoA-IV-containing lipoprotein secretion in differentiated Caco-2 cells: role in cholesterol efflux. J Cell Biochem 83:230–238CrossRef

27.

Nilausen K, Meinertz H (1999) Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein. Am J Clin Nutr 69:419–425

28.

Park J, Floch MH (2007) Prebiotics, probiotics, and dietary fiber in gastrointestinal disease. Gastroenterol Clin North Am 36:47–63CrossRef

29.

Pereira DI, Gibson GR (2002) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37:259–281CrossRef

30.

Randall OS, Feseha HB, Illoh K, Xu S, Ketete M, Kwagyan J, Tilghman C, Wrenn M (2004) Response of lipoprotein(a) to therapeutic life-style change in obese African–Americans. Atherosclerosis 172:155–160CrossRef

31.

Rubin J, Kim HJ, Pearson TA, Holleran S, Ramakrishnan R, Berglund L (2006) Apo(a) size and PNR explain African American–Caucasian differences in allele-specific apo(a) levels for small but not large apo(a). J Lipid Res 47:982–989CrossRef

32.

Silaste ML, Rantala M, Alfthan G, Aro A, Witztum JL, Kesaniemi YA, Hörkkö S (2004) Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a). Arterioscler Thromb Vasc Biol 24:498–503CrossRef

33.

Sofi F, Fatini C, Sticchi E, Lenti M, Gori AM, Giusti B, Fedi S, Casini A, Abbate R, Gensini GF (2007) Fish intake and LPA 93C > T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations. Atherosclerosis 195(2):e147–e154CrossRef

34.

Swain JH, Alekel DL, Dent SB, Peterson CT, Reddy MB (2002) Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women. Am J Clin Nutr 76:165–171

35.

Trommsdorff M, Köchl S, Lingenhel A, Kronenberg F, Delport R, Vermaak H, Lemming L, Klausen IC, Faergeman O, Utermann G, Kraft HG (1995) A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest 96:150–157CrossRef

36.

Utermann G (2001) Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, Medical Publishing Division, New York, pp 2753–2787

37.

Williams CM, Jackson KG (2002) Inulin and oligofructose: effects on lipid metabolism from human studies. Br J Nutr 87(Suppl 2):S261–S264CrossRef

38.

Wood RJ, Volek JS, Davis SR, Dellova C, Fernandez ML (2006) Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab (Lond) 3:19CrossRef

39.

Zorio E, Falco C, Arnau MA, España F, Osa A, Ramon LA, Castello R, Almenar L, Palencia MA, Estelles A (2006) Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions. Haematologica 91:562–565

Title: Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers
Authors: Francesco Russo
Guglielmina Chimienti
Giuseppe Riezzo
Gabriella Pepe
Giuseppe Petrosillo
Marisa Chiloiro
Emanuele Marconi
Publication date: 01-12-2008
Publisher: D. Steinkopff-Verlag
Published in: European Journal of Nutrition / Issue 8/2008
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-008-0748-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aim of the study

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2008

Diet, obesity and obesogenic trends in two generations of Swedish women

An explorative study of in vivo digestive starch characteristics and postprandial glucose kinetics of wholemeal wheat bread

Factors affecting the conversion of apple polyphenols to phenolic acids and fruit matrix to short-chain fatty acids by human faecal microbiota in vitro

B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia

Does ascorbic acid supplementation affect iron bioavailability in rats fed micronized dispersible ferric pyrophosphate fortified fruit juice?

Dietary polyphenols identified as intracellular protein kinase A inhibitors

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials